Amedisys, Inc. (AMED)
Price:
100.99 USD
( + 0.01 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
LHC Group, Inc.
VALUE SCORE:
0
2nd position
Addus HomeCare Corporation
VALUE SCORE:
10
The best
Acadia Healthcare Company, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
NEWS
Joel Greenblatt's Strategic Moves: A Closer Look at SPDR S&P 500 ETF Trust
gurufocus.com
2025-11-14 17:03:00Insights from the Third Quarter 2025 13F Filing Joel Greenblatt (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, providing
Twilio Set to Join S&P MidCap 400
prnewswire.com
2025-08-14 18:08:00NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE: TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE: UNH) acquired Amedisys in a deal completed today.
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors
seekingalpha.com
2025-08-03 23:32:07AMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it fails. Not so for AMED. Aside from this, there are internal factors dragging on AMED's business performance.
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?
zacks.com
2025-08-01 10:41:32Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amedisys (AMED) Q2 Revenue Tops 5%
fool.com
2025-07-30 23:06:31Amedisys (AMED) Q2 Revenue Tops 5%
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
zacks.com
2025-07-29 20:31:06Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates
zacks.com
2025-07-29 18:55:35Amedisys (AMED) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.32 per share a year ago.
Amedisys Reports Second Quarter 2025 Financial Results
globenewswire.com
2025-07-29 16:45:00BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025.
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
zacks.com
2025-06-13 09:30:27Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
AMED or CHE: Which Is the Better Value Stock Right Now?
zacks.com
2025-05-23 12:41:04Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Are Medical Stocks Lagging Amedisys (AMED) This Year?
zacks.com
2025-05-23 10:45:37Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
zacks.com
2025-04-24 08:25:35Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care.
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
zacks.com
2025-04-23 21:30:35Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Amedisys (AMED) Tops Q1 Earnings Estimates
zacks.com
2025-04-23 18:55:31Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago.
Amedisys Reports First Quarter 2025 Financial Results
globenewswire.com
2025-04-23 16:45:00BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025.
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
zacks.com
2025-04-16 11:06:05Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
No data to display
Joel Greenblatt's Strategic Moves: A Closer Look at SPDR S&P 500 ETF Trust
gurufocus.com
2025-11-14 17:03:00Insights from the Third Quarter 2025 13F Filing Joel Greenblatt (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, providing
Twilio Set to Join S&P MidCap 400
prnewswire.com
2025-08-14 18:08:00NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE: TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE: UNH) acquired Amedisys in a deal completed today.
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors
seekingalpha.com
2025-08-03 23:32:07AMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it fails. Not so for AMED. Aside from this, there are internal factors dragging on AMED's business performance.
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?
zacks.com
2025-08-01 10:41:32Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amedisys (AMED) Q2 Revenue Tops 5%
fool.com
2025-07-30 23:06:31Amedisys (AMED) Q2 Revenue Tops 5%
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
zacks.com
2025-07-29 20:31:06Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates
zacks.com
2025-07-29 18:55:35Amedisys (AMED) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.32 per share a year ago.
Amedisys Reports Second Quarter 2025 Financial Results
globenewswire.com
2025-07-29 16:45:00BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025.
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
zacks.com
2025-06-13 09:30:27Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
AMED or CHE: Which Is the Better Value Stock Right Now?
zacks.com
2025-05-23 12:41:04Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
Are Medical Stocks Lagging Amedisys (AMED) This Year?
zacks.com
2025-05-23 10:45:37Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
zacks.com
2025-04-24 08:25:35Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care.
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
zacks.com
2025-04-23 21:30:35Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Amedisys (AMED) Tops Q1 Earnings Estimates
zacks.com
2025-04-23 18:55:31Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago.
Amedisys Reports First Quarter 2025 Financial Results
globenewswire.com
2025-04-23 16:45:00BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025.
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
zacks.com
2025-04-16 11:06:05Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.